QuidelOrtho Corporation

Fundamentals4.0
Price Action6.0
News Sentiment5.0
AI Rating
4.0

Key Drivers

  • High gross margins
  • Large operating losses
  • Heavy leverage/intangibles

AI
AI Summary

4.0

Reframe QDEL as a carry‑trade: management has materially improved margins and returned to positive quarterly FCF, but the equity remains highly levered and vulnerable until net debt/EBITDA meaningfully falls (target ≤2.5x) and early commercial wins (LEX/Savanna/fentanyl) prove scalable. Actionable trigger points: require consecutive quarters of positive FCF, clear deleveraging progress, and initial product revenue pickup before treating this as anything more than a speculative, event‑driven recovery.

OperationalRecovery
LeverageRisk
EventDriven‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

4.0

Key Financial Insights:

  • High gross margins
  • Large operating losses
  • Heavy leverage/intangibles

QDEL shows healthy gross margins but is loss-making and highly leveraged with heavy intangibles—recent quarterly EBITDA and FCF improvements suggest a possible near-term recovery but significant solvency and impairment risks remain. ,

leverage
turnaround

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below last-month average
  • Recent distribution
  • Episodic bounces

QDEL is in a short-term downtrend—closing $15.24 on 2026-03-20 roughly 19% below its last-month moving average after sliding from the $21–23 area into the mid-teens, with immediate support at $15.24 and resistance $21.00–$23.50 (failure below $15.24 is bearish; reclaiming $21–$23 would shift momentum).

bearish
watchlist
Support Level: $15.24
Resistance Level: $21.00–$23.50

Consistent slide from the $21–23 area into mid-teens over late

Sentiment & News

5.0

Key News Insights:

  • Earnings-driven selloff
  • Mixed institutional flows
  • Insider purchase

QuidelOrtho shares fell sharply after earnings while major holders both trimmed and boosted positions and an insider bought stock amid CFO retirement, signaling investor repositioning.

repositioning
insiderbuy

The mix of large-scale buying and selling plus an insider buy suggests elevated volatility and investor reassessment, likely keeping pressure on the stock near term